Abstract:
The present work involves the development and validation of a simple, accurate and
precise Simultaneous Equation Method UV-spectroscopy and RP-HPLC Method for the
assay of Febuxostat and Diclofenac Potassium.
Simple, specific, accurate, precise and reproducible method have been developed and
validated for the simultaneous estimation of both drugs in their combined dosage form.
UV- SPECTROPHOTOMETRIC METHOD was a determination using the
Simultaneous Equation Method UV-spectroscopy at 314 nm and 277nm over the
concentration range 4-14 μg/ml for Febuxostat and 10-35 μg/ml for Diclfoenac Potassium
in 0.1 N NaOH respectively. The % recoveries of the both the drugs (in sample
preparation) were found to be 100.67-101.5 % for Febuxostat and 100.15-101.9
% for Diclofenac Potassium respectively. The % recoveries of the both the drugs (in bulk
preparation) were found to be 99.87-100.83 % and 99.84-100.67% respectively. THE RP-HPLC METHOD has shown adequate separation of Febuxostat And
Diclofenac Potassium in bulk and it’s tablet dosage Form. The separation was achieved on
a Enable C18 (250mm X 4.6 mm i.d., 5 μm particle size) with a gradient system of ACN:
Methanol: water (30:30:40) pH 5 adjusted with O-phosphoric acid and TEA. The mobile
phase at a flow rate of 1.0 ml/min, Injection volume 20μl and wavelength of detection
used was 280 nm. The retention time Febuxostat and Diclofenac Potassium for was
obtained as 3.0±0.1min and 4.4±0.1min, respectively. The linearity of the proposed
method was investigated in the range of 4-24 μg/ml and 10-60 μg/ml for Febuxostat and
Diclofenac Potassium, respectively. Correlation coefficient was 0.998 and 0.998 for
Febuxostat and Diclofenac Potassium Respectively. The developed method was validated
as per ICH guideline, for its accuracy, precision, LOD & LOQ and the results were found
to be satisfactory, thus the method is specific, rapid and simple with good sensitivity for
estimation of Febuxostat and Diclofenac Potassium. These analytical methods are also
applicable in ordinary laboratories. It can also be adopted for quality control tests for these
drugs in tablets.
